Page breadcrumb nav

VAERS Report 2156838

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: unknown


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2021-12-14
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

psoriasis/ then again with full diagnosis given after pfizer second dose./ never had psoriasis before, now have the new diagnosis.; off label use; interchange of vaccine products; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202190047364580-wua9i (ra). other case identifier: gb-mhra-adr 26624081 (ra). a female patient received bnt162b2 (comirnaty), administration date 14dec2021 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "suspected covid-19", start date: 09mar2020 (unspecified if ongoing), notes: unsure when symptoms stopped; "have other autoimmunity" (unspecified if ongoing), notes: have other autoimmunity but never had psoriasis before, now have the new diagnosis. the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine astrazeneca (dose 1), for covid-19 immunisation, reaction(s): "psoriasis of skin and nail after az vaccine first dose". the following information was reported: off label use (medically significant) with onset 14dec2021, outcome "unknown", described as "off label use"; interchange of vaccine products (medically significant) with onset 14dec2021, outcome "unknown", described as "interchange of vaccine products"; psoriasis (medically significant), outcome "not recovered", described as "psoriasis/ then again with full diagnosis given after pfizer second dose./ never had psoriasis before, now have the new diagnosis.". the event "psoriasis/ then again with full diagnosis given after pfizer second dose./ never had psoriasis before, now have the new diagnosis." was evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: scan: unknown results. additional information: psoriasis of skin and nail after az vaccine first dose and then again with full diagnosis given by a consultant dermatologist after pfizer second dose. have other autoimmunity but never had psoriasis before, now had new diagnosis. patient has not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Lab Data
test name: consultant dermatologist diagnosis; result unstructured data: test result:unknown results
List of symptoms
psoriasis interchange of vaccine products scan off label use
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na